Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Clinical and MRI efficacy of sc IFN β-1a tiw in patients with relapsing MS appearing to transition to secondary progressive MS: post hoc analyses of PRISMS and SPECTRIMS.

Freedman MS, Brod S, Singer BA, Cohen BA, Hayward B, Dangond F, Coyle PK.

J Neurol. 2020 Jan;267(1):64-75. doi: 10.1007/s00415-019-09532-5. Epub 2019 Sep 26.

PMID:
31559532
2.

Fragile X syndrome in a male with methylated premutation alleles and no detectable methylated full mutation alleles.

Hayward B, Loutaev I, Ding X, Nolin SL, Thurm A, Usdin K, Smith CB.

Am J Med Genet A. 2019 Oct;179(10):2132-2137. doi: 10.1002/ajmg.a.61286. Epub 2019 Jul 29.

PMID:
31356000
3.

That was a game changer: clinical impact of an emergency department-based palliative care communication skills training workshop.

Wright R, Hayward B, Kistler E, Vaughan Dickson V, Grudzen C.

Emerg Med J. 2019 Jul 26. pii: emermed-2019-208567. doi: 10.1136/emermed-2019-208567. [Epub ahead of print]

PMID:
31350282
4.

Evaluation of an embryology and genetic testing patient counseling education intervention for reproductive endocrinology nurses.

Catherino AB, Halupa C, Sharara FI, Bromer JG, Hayward B, Catherino WH.

Fertil Steril. 2019 Aug;112(2):275-282.e1. doi: 10.1016/j.fertnstert.2019.04.005. Epub 2019 Jun 11.

PMID:
31200972
5.

Glutaminase Deficiency Caused by Short Tandem Repeat Expansion in GLS.

van Kuilenburg ABP, Tarailo-Graovac M, Richmond PA, Drögemöller BI, Pouladi MA, Leen R, Brand-Arzamendi K, Dobritzsch D, Dolzhenko E, Eberle MA, Hayward B, Jones MJ, Karbassi F, Kobor MS, Koster J, Kumari D, Li M, MacIsaac J, McDonald C, Meijer J, Nguyen C, Rajan-Babu IS, Scherer SW, Sim B, Trost B, Tseng LA, Turkenburg M, van Vugt JJFA, Veldink JH, Walia JS, Wang Y, van Weeghel M, Wright GEB, Xu X, Yuen RKC, Zhang J, Ross CJ, Wasserman WW, Geraghty MT, Santra S, Wanders RJA, Wen XY, Waterham HR, Usdin K, van Karnebeek CDM.

N Engl J Med. 2019 Apr 11;380(15):1433-1441. doi: 10.1056/NEJMoa1806627.

PMID:
30970188
6.

Assays for Determining Repeat Number, Methylation Status, and AGG Interruptions in the Fragile X-Related Disorders.

Hayward BE, Usdin K.

Methods Mol Biol. 2019;1942:49-59. doi: 10.1007/978-1-4939-9080-1_4.

PMID:
30900174
7.

Repeat Instability in the Fragile X-Related Disorders: Lessons from a Mouse Model.

Zhao X, Gazy I, Hayward B, Pintado E, Hwang YH, Tassone F, Usdin K.

Brain Sci. 2019 Mar 1;9(3). pii: E52. doi: 10.3390/brainsci9030052.

8.

Double-strand break repair plays a role in repeat instability in a fragile X mouse model.

Gazy I, Hayward B, Potapova S, Zhao X, Usdin K.

DNA Repair (Amst). 2019 Feb;74:63-69. doi: 10.1016/j.dnarep.2018.12.004. Epub 2018 Dec 21.

PMID:
30606610
9.

Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance.

Sabidó M, Venkatesh S, Hayward B, Aldridge J, Gillett A.

Adv Ther. 2018 Nov;35(11):2041-2053. doi: 10.1007/s12325-018-0790-1. Epub 2018 Sep 25.

10.

The Impact of Activity Based Working (ABW) on Workplace Activity, Eating Behaviours, Productivity, and Satisfaction.

Arundell L, Sudholz B, Teychenne M, Salmon J, Hayward B, Healy GN, Timperio A.

Int J Environ Res Public Health. 2018 May 17;15(5). pii: E1005. doi: 10.3390/ijerph15051005.

11.

Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.

Wray S, Hayward B, Dangond F, Singer B.

Expert Opin Drug Deliv. 2018 Feb;15(2):127-135. doi: 10.1080/17425247.2018.1407755. Epub 2017 Dec 5.

PMID:
29206056
12.

Recent advances in assays for the fragile X-related disorders.

Hayward BE, Kumari D, Usdin K.

Hum Genet. 2017 Oct;136(10):1313-1327. doi: 10.1007/s00439-017-1840-5. Epub 2017 Sep 2. Review.

13.

Estimated reduction in expenditure on hospital-acquired pressure injuries after an intervention for early identification and treatment.

Lewis H, Hughes D, Madell D, Coomarasamy C, Villa L, Hayward B.

N Z Med J. 2017 Sep 1;130(1461):42-46.

PMID:
28859065
14.

Improved Assays for AGG Interruptions in Fragile X Premutation Carriers.

Hayward BE, Usdin K.

J Mol Diagn. 2017 Nov;19(6):828-835. doi: 10.1016/j.jmoldx.2017.06.008. Epub 2017 Aug 14.

15.

A tubulin alpha 8 mouse knockout model indicates a likely role in spermatogenesis but not in brain development.

Diggle CP, Martinez-Garay I, Molnar Z, Brinkworth MH, White E, Fowler E, Hughes R, Hayward BE, Carr IM, Watson CM, Crinnion L, Asipu A, Woodman B, Coletta PL, Markham AF, Dear TN, Bonthron DT, Peckham M, Morrison EE, Sheridan E.

PLoS One. 2017 Apr 7;12(4):e0174264. doi: 10.1371/journal.pone.0174264. eCollection 2017.

16.

My Home is My Marae: Kaupapa Māori evaluation of an approach to injury prevention.

Hayward B, Lyndon M, Villa L, Madell D, Elliot-Hohepa A, Le Comte L.

BMJ Open. 2017 Mar 20;7(3):e013811. doi: 10.1136/bmjopen-2016-013811.

17.

The Human Oocyte Preservation Experience (HOPE) Registry: evaluation of cryopreservation techniques and oocyte source on outcomes.

Nagy ZP, Anderson RE, Feinberg EC, Hayward B, Mahony MC.

Reprod Biol Endocrinol. 2017 Feb 7;15(1):10. doi: 10.1186/s12958-017-0228-7.

18.

Evaluation of general practice house officer attachments in Counties Manukau: insights and benefits.

Le Comte L, Hayward B, Hughes D, Villa L, Madell D.

J Prim Health Care. 2016 Dec;8(4):288-294. doi: 10.1071/HC16001.

PMID:
29530152
19.

Pathways of Acetyl-CoA Metabolism Involved in the Reversal of Palmitate-Induced Glucose Production by Metformin and Salicylate.

Hayward B, Molero JC, Windmill K, Sanigorski A, Weir J, McRae NL, Aston-Mourney K, Osborne B, Liao B, Walder KR, Meikle PJ, Konstantopoulos N, Schmitz-Peiffer C.

Exp Clin Endocrinol Diabetes. 2016;124(10):602-612. doi: 10.1055/s-0042-111516. Epub 2016 Sep 29.

PMID:
27684726
20.

A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders.

Hayward BE, Zhou Y, Kumari D, Usdin K.

J Mol Diagn. 2016 Sep;18(5):762-774. doi: 10.1016/j.jmoldx.2016.06.001. Epub 2016 Aug 12.

21.

Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.

Tao Y, Zhang X, Zivadinov R, Dwyer MG, Kennedy C, Bergsland N, Ramasamy D, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B, Markovic-Plese S.

Neurol Neuroimmunol Neuroinflamm. 2015 Nov 12;2(6):e176. doi: 10.1212/NXI.0000000000000176. eCollection 2015 Dec.

22.

Immunological and short-term brain volume changes in relapsing forms of multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: an open-label two-arm trial.

Dwyer MG, Zivadinov R, Tao Y, Zhang X, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Weinstock-Guttman B, Hayward B, Dangond F, Markovic-Plese S.

BMC Neurol. 2015 Nov 11;15:232. doi: 10.1186/s12883-015-0488-9.

23.

Predictors of Treatment Response to Tesamorelin, a Growth Hormone-Releasing Factor Analog, in HIV-Infected Patients with Excess Abdominal Fat.

Mangili A, Falutz J, Mamputu JC, Stepanians M, Hayward B.

PLoS One. 2015 Oct 12;10(10):e0140358. doi: 10.1371/journal.pone.0140358. eCollection 2015.

24.

Evidence for chromosome fragility at the frataxin locus in Friedreich ataxia.

Kumari D, Hayward B, Nakamura AJ, Bonner WM, Usdin K.

Mutat Res. 2015 Nov;781:14-21. doi: 10.1016/j.mrfmmm.2015.08.007. Epub 2015 Aug 30.

25.

A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.

Zivadinov R, Dwyer M, Markovic-Plese S, Hayward B, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Dangond F, Weinstock-Guttman B.

Ther Adv Neurol Disord. 2015 Mar;8(2):59-70. doi: 10.1177/1756285615572953.

26.

Human factors engineering and design validation for the redesigned follitropin alfa pen injection device.

Mahony MC, Patterson P, Hayward B, North R, Green D.

Expert Opin Drug Deliv. 2015 May;12(5):715-25. doi: 10.1517/17425247.2015.1033395.

27.

Associations between changes in ferritin levels and susceptibility-weighted imaging filtered phase in patients with relapsing-remitting multiple sclerosis over 24 weeks of therapy with subcutaneous interferon beta-1a three times weekly.

Dwyer MG, Zivadinov R, Markovic-Plese S, Bergsland N, Heininen-Brown M, Carl E, Kennedy C, Weinstock-Guttman B, Hayward B, Dangond F.

J Neuroimmunol. 2015 Apr 15;281:44-50. doi: 10.1016/j.jneuroim.2015.03.002. Epub 2015 Mar 5.

28.

HEATR2 plays a conserved role in assembly of the ciliary motile apparatus.

Diggle CP, Moore DJ, Mali G, zur Lage P, Ait-Lounis A, Schmidts M, Shoemark A, Garcia Munoz A, Halachev MR, Gautier P, Yeyati PL, Bonthron DT, Carr IM, Hayward B, Markham AF, Hope JE, von Kriegsheim A, Mitchison HM, Jackson IJ, Durand B, Reith W, Sheridan E, Jarman AP, Mill P.

PLoS Genet. 2014 Sep 18;10(9):e1004577. doi: 10.1371/journal.pgen.1004577. eCollection 2014 Sep.

29.

Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders.

Usdin K, Hayward BE, Kumari D, Lokanga RA, Sciascia N, Zhao XN.

Front Genet. 2014 Jul 17;5:226. doi: 10.3389/fgene.2014.00226. eCollection 2014. Review.

30.

Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.

Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, Weinstock-Guttman B.

PLoS One. 2014 Mar 13;9(3):e91098. doi: 10.1371/journal.pone.0091098. eCollection 2014.

31.

Chromosome fragility and the abnormal replication of the FMR1 locus in fragile X syndrome.

Yudkin D, Hayward BE, Aladjem MI, Kumari D, Usdin K.

Hum Mol Genet. 2014 Jun 1;23(11):2940-52. doi: 10.1093/hmg/ddu006. Epub 2014 Jan 12.

PMID:
24419320
32.

SAMHD1-dependent retroviral control and escape in mice.

Rehwinkel J, Maelfait J, Bridgeman A, Rigby R, Hayward B, Liberatore RA, Bieniasz PD, Towers GJ, Moita LF, Crow YJ, Bonthron DT, Reis e Sousa C.

EMBO J. 2013 Sep 11;32(18):2454-62. doi: 10.1038/emboj.2013.163. Epub 2013 Jul 19.

33.

Simple detection of germline microsatellite instability for diagnosis of constitutional mismatch repair cancer syndrome.

Ingham D, Diggle CP, Berry I, Bristow CA, Hayward BE, Rahman N, Markham AF, Sheridan EG, Bonthron DT, Carr IM.

Hum Mutat. 2013 Jun;34(6):847-52. doi: 10.1002/humu.22311. Epub 2013 Apr 2.

PMID:
23483711
34.

Rebif(®) Quality of Life (RebiQoL): A randomized, multicenter, Phase IIIb study evaluating quality-of-life measures in patients receiving the serum-free formulation of subcutaneous interferon beta-1a for the treatment of relapsing forms of multiple sclerosis.

Bandari D, Wynn D, Miller T, Singer B, Wray S, Bennett R, Hayward B, Dangond F; RebiQoL Study Group.

Mult Scler Relat Disord. 2013 Jan;2(1):45-56. doi: 10.1016/j.msard.2012.07.005. Epub 2012 Sep 25.

PMID:
25877454
35.

Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration.

Koenekoop RK, Wang H, Majewski J, Wang X, Lopez I, Ren H, Chen Y, Li Y, Fishman GA, Genead M, Schwartzentruber J, Solanki N, Traboulsi EI, Cheng J, Logan CV, McKibbin M, Hayward BE, Parry DA, Johnson CA, Nageeb M; Finding of Rare Disease Genes (FORGE) Canada Consortium, Poulter JA, Mohamed MD, Jafri H, Rashid Y, Taylor GR, Keser V, Mardon G, Xu H, Inglehearn CF, Fu Q, Toomes C, Chen R.

Nat Genet. 2012 Sep;44(9):1035-9. doi: 10.1038/ng.2356. Epub 2012 Jul 29.

36.

Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours.

Cookson VJ, Bentley MA, Hogan BV, Horgan K, Hayward BE, Hazelwood LD, Hughes TA.

Cell Oncol (Dordr). 2012 Aug;35(4):301-8. doi: 10.1007/s13402-012-0089-1. Epub 2012 Jul 21.

PMID:
22821209
37.

Recurrent hydatidiform mole: detection of two novel mutations in the NLRP7 gene in two Egyptian families.

Abdalla EM, Hayward BE, Shamseddin A, Nawar MM.

Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):211-5. doi: 10.1016/j.ejogrb.2012.06.017. Epub 2012 Jul 4.

PMID:
22770628
38.

Patient-rated ease of use and functional reliability of an electronic autoinjector for self-injection of subcutaneous interferon beta-1a for relapsing multiple sclerosis.

Singer B, Wray S, Miller T, Cascione M, Gupta A, Pardo G, Watsky E, Hayward B, Mercer B, Dangond F.

Mult Scler Relat Disord. 2012 Apr;1(2):87-94. doi: 10.1016/j.msard.2011.11.002. Epub 2012 Jan 20.

PMID:
25876936
39.

Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study.

Wray S, Armstrong R, Herrman C, Calkwood J, Cascione M, Watsky E, Hayward B, Mercer B, Dangond F.

Expert Opin Drug Deliv. 2011 Dec;8(12):1543-53. doi: 10.1517/17425247.2011.628656. Epub 2011 Oct 27.

PMID:
22032264
40.

Mutations causing familial biparental hydatidiform mole implicate c6orf221 as a possible regulator of genomic imprinting in the human oocyte.

Parry DA, Logan CV, Hayward BE, Shires M, Landolsi H, Diggle C, Carr I, Rittore C, Touitou I, Philibert L, Fisher RA, Fallahian M, Huntriss JD, Picton HM, Malik S, Taylor GR, Johnson CA, Bonthron DT, Sheridan EG.

Am J Hum Genet. 2011 Sep 9;89(3):451-8. doi: 10.1016/j.ajhg.2011.08.002. Epub 2011 Sep 1.

41.

Both isoforms of ketohexokinase are dispensable for normal growth and development.

Diggle CP, Shires M, McRae C, Crellin D, Fisher J, Carr IM, Markham AF, Hayward BE, Asipu A, Bonthron DT.

Physiol Genomics. 2010 Nov 29;42A(4):235-43. doi: 10.1152/physiolgenomics.00128.2010. Epub 2010 Sep 14.

PMID:
20841500
42.

Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens.

Wood HM, Belvedere O, Conway C, Daly C, Chalkley R, Bickerdike M, McKinley C, Egan P, Ross L, Hayward B, Morgan J, Davidson L, MacLennan K, Ong TK, Papagiannopoulos K, Cook I, Adams DJ, Taylor GR, Rabbitts P.

Nucleic Acids Res. 2010 Aug;38(14):e151. doi: 10.1093/nar/gkq510. Epub 2010 Jun 4.

43.

Genetic diagnosis of familial breast cancer using clonal sequencing.

Morgan JE, Carr IM, Sheridan E, Chu CE, Hayward B, Camm N, Lindsay HA, Mattocks CJ, Markham AF, Bonthron DT, Taylor GR.

Hum Mutat. 2010 Apr;31(4):484-91. doi: 10.1002/humu.21216.

PMID:
20127978
44.

Mutation of the variant alpha-tubulin TUBA8 results in polymicrogyria with optic nerve hypoplasia.

Abdollahi MR, Morrison E, Sirey T, Molnar Z, Hayward BE, Carr IM, Springell K, Woods CG, Ahmed M, Hattingh L, Corry P, Pilz DT, Stoodley N, Crow Y, Taylor GR, Bonthron DT, Sheridan E.

Am J Hum Genet. 2009 Nov;85(5):737-44. doi: 10.1016/j.ajhg.2009.10.007. Epub 2009 Nov 5.

45.

Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII.

Recht M, Nemes L, Matysiak M, Manco-Johnson M, Lusher J, Smith M, Mannucci P, Hay C, Abshire T, O'Brien A, Hayward B, Udata C, Roth DA, Arkin S.

Haemophilia. 2009 Jul;15(4):869-80. doi: 10.1111/j.1365-2516.2009.02027.x. Epub 2009 Apr 9.

PMID:
19473411
46.

IBDfinder and SNPsetter: tools for pedigree-independent identification of autozygous regions in individuals with recessive inherited disease.

Carr IM, Sheridan E, Hayward BE, Markham AF, Bonthron DT.

Hum Mutat. 2009 Jun;30(6):960-7. doi: 10.1002/humu.20974.

PMID:
19405095
47.

Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme.

Diggle CP, Shires M, Leitch D, Brooke D, Carr IM, Markham AF, Hayward BE, Asipu A, Bonthron DT.

J Histochem Cytochem. 2009 Aug;57(8):763-74. doi: 10.1369/jhc.2009.953190. Epub 2009 Apr 13.

48.

Genetic and epigenetic analysis of recurrent hydatidiform mole.

Hayward BE, De Vos M, Talati N, Abdollahi MR, Taylor GR, Meyer E, Williams D, Maher ER, Setna F, Nazir K, Hussaini S, Jafri H, Rashid Y, Sheridan E, Bonthron DT.

Hum Mutat. 2009 May;30(5):E629-39. doi: 10.1002/humu.20993.

PMID:
19309689
49.

Gas bubbles in seals, dolphins, and porpoises entangled and drowned at depth in gillnets.

Moore MJ, Bogomolni AL, Dennison SE, Early G, Garner MM, Hayward BA, Lentell BJ, Rotstein DS.

Vet Pathol. 2009 May;46(3):536-47. doi: 10.1354/vp.08-VP-0065-M-FL. Epub 2009 Jan 27.

PMID:
19176498
50.

A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS).

Churchman SM, Church LD, Savic S, Coulthard LR, Hayward B, Nedjai B, Turner MD, Mathews RJ, Baguley E, Hitman GA, Gooi HC, Wood PM, Emery P, McDermott MF.

Ann Rheum Dis. 2008 Nov;67(11):1589-95. Epub 2007 Dec 17.

PMID:
18086728

Supplemental Content

Loading ...
Support Center